BioSpace News Archive

BGI Americas, a genomics services leader, and Gencove, a leading genomics technology company, announced today that they have entered into an agreement to offer a new low-pass sequencing service to lower barriers to large-scale genomics projects.

Invacare Corporation announces that it will release its financial results for the third quarter ended September 30, 2018, after the market closes on Monday, November 5, 2018.

Dr. Alise Reicin will lead mid- to late-stage drug development across Celgene’s portfolio

Court finds headgear used on Simplus and Eson 2 CPAP masks infringes ResMed patent

In U-ACHIEVE, upadacitinib (15/30/45 mg, once daily) met the primary endpoint of clinical remission (per Adapted Mayo Score) and all ranked secondary endpoints, including endoscopic improvement, clinical remission (per Full Mayo Score) and clinical response, in patients with moderately to severely active ulcerative colitis[1]

Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, overall manufacturer performance, overall system performance and overall service performance in the ServiceTrak Imaging 2018 report on radiation oncology accelerator manufacturers published by IMV Medical Information Division.

PinneyAssociates is pleased to welcome Judy Ashworth, M.D., as Chief Medical Officer and Bernie Simone as Vice President, Client Strategy and Rx-to-OTC Switch

Biodesix® presented positive data for a blood-based test with the potential to detect a non-small cell lung cancer (NSCLC) patient’s pre-treatment risk of anti-PD-1 immunotherapy resistance. Dr. Egbert Smit, MD, PhD, a leader in pulmonary oncology at the Netherlands Cancer Institute, Department of Thoracic Oncology in Amsterdam,

EKF Diagnostics, the global in vitro diagnostics company, announces that on Stand C70 in Hall 3 of MEDICA 2018, it will be launching its new Lactate Scout 4 hand-held lactate analyzer for fast and accurate sports performance monitoring.

GlyTR Therapeutics, Inc. is pleased to announce it has been awarded an approximately $300,000 grant from The National Cancer Institute (NCI), National Institute of Health (NIH) thru the Small Business Technology Transfer Program.